Zyga Technology Updates on SImmetry Sacroiliac Joint Fusion Clinical Study

Zyga Technology reported the first patient enrollment in Sacroiliac Fusion Study, a prospective, single-arm post-market study designed to evaluate fusion and pain reduction following use of the SImmetry Sacroiliac Joint Fusion System.

In a release, the Company noted that the study will be performed at a single center and will include up to 15 patients.

<p>"Clinical studies such as SAIF are critical to demonstrate the empirical value of Sacroiliac Joint Fusion," said Noel Goldthwaite, who performed the surgery. "This kind of objective data may show payers, other physicians, and of course those suffering from SI Joint Dysfunction the clinical and economic benefits of true SI Joint arthrodesis including decortication and bone grafting."

"The introduction of the SImmetry System, a minimally invasive SI Joint fusion procedure that utilizes proven orthopedic principles of decortication, grafting and fixation, is the first step in providing a viable treatment option for SI Joint Dysfunction," said Jim Bullock, president and chief executive officer of Zyga. "Now, through SAIF and additional planned clinical studies, we will demonstrate the clinical and economic value of the true SI Joint arthrodesis allowing for consistent insurance coverage and availability to patients in need."

((Comments on this story may be sent to [email protected]))